The first 29 amino acids of human GHRH — the gold-standard peptide for studying natural GH axis function.
A mitochondria-targeting antioxidant tetrapeptide studied for cardiac, renal, and muscular recovery research.
A mitochondria-targeted antioxidant peptide studied for cellular energy protection and recovery at the mitochondrial level.
A synthetic Thymosin Beta-4 analogue studied for accelerated tissue repair, anti-inflammatory action, and enhanced recovery.
Double-strength Tesamorelin vial for extended GHRH research and high-throughput protocols.
A GHRH analogue studied for stimulating growth hormone release and reducing visceral adipose tissue.
A thymic gland polypeptide bioregulator studied for immune system restoration and anti-aging research.
Double-dose thymic immunomodulatory peptide for extended T-cell and innate immunity research.
A thymus-derived immunomodulatory peptide studied for T-cell activation, immune enhancement, and antiviral research.
Smaller TB-500 format for introductory tissue repair and recovery research.
A dual GIP and GLP-1 receptor agonist studied for metabolic disease and weight regulation research.
A vascular system bioregulator peptide studied for endothelial function and blood vessel health research.
A dipeptide thymic bioregulator studied for immune restoration and anti-aging research.
A pleiotropic neuropeptide studied for immune regulation, neurological function, and anti-inflammatory activity.
